Loading...
*  Leprosy in China
... rifampicin and clofazimine. Today, therapy takes six months to a year. MDT treatment has been made available by the WHO free of ...
*  Clofazimine
... is a phenazine dye and believed to work by interfering with DNA. Clofazimine was approved for medical use in the ... Clofazimine is marketed under the trade name Lamprene by Novartis. One of the world's only producers of the clofazimine ... Clofazimine is also a FIASMA (functional inhibitor of acid sphingomyelinase). Clofazimine has a biological half life of about ... Macrophages were first reported to be inhibited due to the stabilization of lysosomal membrane by clofazimine. Clofazimine also ...
*  KCNA3
... progesterone and the anti-lepromatous drug clofazimine). Interestingly, the Kv1.3 blocker clofazimine has been reported to be ... "Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes". PLoS ONE. 3 (12): e4009 ... Furthermore, clofazimine in combination with the antibiotics clarithromycin and rifabutin induced remission for about 2 years ... Arbiser JL, Moschella SL (February 1995). "Clofazimine: a review of its medical uses and mechanisms of action". J. Am. Acad. ...
*  Multi-drug-resistant tuberculosis
imipenem co-amoxiclav clofazimine prochlorperazine metronidazole On December 28, 2012 the U.S. Food and Drug Administration ( ... Jagannath, C; Reddy, M V; Kailasam, S; O'Sullivan, J F; Gangadharam, P R (1995). "Chemotherapeutic activity of clofazimine and ... Janulionis, E.; Sofer, C.; Song, H.-Y.; Wallis, R. S. (2004). "Lack of Activity of Orally Administered Clofazimine against ... "Effective Treatment of Acute and Chronic Murine Tuberculosis with Liposome-Encapsulated Clofazimine". Antimicrobial Agents and ...
*  Leprostatic agent
Clofazimine is a weakly bactericidal dye that has some activity against M. leprae. Its precise mechanism of action is unknown ... Clofazimine is given to treat sulfone-resistant leprosy or to patients who are intolerant to sulfones. It also exerts an ... Clofazimine achieves significant concentrations in tissues, including the phagocytic cells; it has a plasma half-life of 70 ... The most disturbing adverse reaction to clofazimine is a red-brown discoloration of the skin, especially in light-skinned ...
*  Febrile neutrophilic dermatosis
Other alternatives to corticosteroid treatment include dapsone, doxycycline, clofazimine, and cyclosporine. All of these drugs ...
*  Stanley George Browne
While in Nigeria, he pioneered the use of anti-leprosy drug, clofazimine. Browne returned to England 1965 and used his vast ...
*  Management of Crohn's disease
Rifabutin, clarithromycin and clofazimine are antibiotics designed to attack mycobacterium avium subsp. paratuberculosis, which ...
*  Mycobacterium kubicae
Susceptibility to clarithromycin, clofazimine and ethionamide has been detected for some strains. The type strain of M. kubicae ...
*  Rifabutin
"Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease". Gastroenterology ...
*  Promin
Today, the drugs of choice for treating leprosy are dapsone, rifampicin and clofazimine. Leo B. Slater (2009). War and disease ...
*  Leprosy
The search for further effective antileprosy drugs led to the use of clofazimine and rifampicin in the 1960s and 1970s. Later, ... While for multibacillary (MB or lepromatous) cases, treatment with daily dapsone and clofazimine along with monthly rifampicin ... Treatment for multibacillary leprosy consists of rifampicin, dapsone, and clofazimine for 12 months. A number of other ...
*  Bedaquiline
Other medications for tuberculosis that can prolong the QT interval include fluoroquinolones and clofazimine. Bedaquiline ...
*  Vincent Barry
He is known for leading the team which developed the anti-leprosy drug clofazimine. Barry was born in Sunday's Well, Cork. He ... He led a team of scientists at Trinity College, Dublin to discover the anti-leprosy drug clofazimine. Barry and his team were ...
*  Dapsone
... is commonly used in combination with rifampicin and clofazimine for the treatment of leprosy. It is also used to both ... is an antibiotic commonly used in combination with rifampicin and clofazimine for the treatment of leprosy. It is a second-line ...
*  Cheilitis
Clofazimine, Clomipramine, Cyancobalamin, Gold, Methyldopa, Psoralens, Streptomycin, Sulfasalazine and Tetracycline. A ...
*  Giaconda (pharmaceutical company)
... clarithromycin and clofazimine. The combination is envisaged as a new treatment for Crohn's Disease. Myoconda was first devised ...
*  Thazhakkara
It is also one of the only companies in the world to manufacture clofazimine[citation needed]. [1]. ...
*  Lacazia
While there yet appears no optional medical therapy, clofazimine has been effective in some cases with lobomycosis. It is a ...
*  Mycobacterium leprae
... rifampicin and clofazimine. In patients receiving the MDT, a high proportion of the bacilli die within a short amount of time ...
*  Timeline of Irish inventions and discoveries
1954: Clofazimine first synthesized by a medical research team led by Cork man Vincent Barry at Trinity College, Dublin. 1965: ...
*  History of leprosy
The search for more effective anti-leprosy drugs led to the use of clofazimine and rifampicin in the 1960s and 1970s. Later, ... The search for additional anti-leprosy drugs led to the use of clofazimine and rifampicin in the 1960s and 1970s. Later, Indian ...
*  Lucio's phenomenon
... is treated by anti-leprosy therapy (dapsone, rifampin, and clofazimine), optimal wound care, and treatment ...
*  Diffuse leprosy of Lucio and LatapĂ­
Lucio's phenomenon is treated by anti-leprosy therapy (dapsone, rifampin, and clofazimine), optimal wound care, and treatment ...